KELLIE GUARINO: Open Payments
NPI 1679274138 · MARLTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,066 in 63 payments from 11 companies in 2025. Trend: 2023 $570 · 2024 $1,089 · 2025 $1,066
Food & beverage: $955Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 12 | $266 |
| Neurocrine BioSciences, Inc. | 18 | $251 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $162 |
| E.R. Squibb & Sons, L.L.C. | 5 | $89 |
| Vanda Pharmaceuticals Inc. | 5 | $87 |
| Otsuka America Pharmaceutical, Inc. | 5 | $86 |
| Alkermes, Inc. | 2 | $39 |
| Janssen Pharmaceuticals, Inc | 2 | $31 |
| ABBVIE INC. | 1 | $19 |
| Lundbeck LLC | 1 | $18 |
Products named: INGREZZA, CAPLYTA, AUSTEDO XR, REXULTI, COBENFY, FANAPT, LYBALVI, INVEGA.
Industry payments across NJ — which companies pay providers there.
